World Health Organization grants emergency use authorization to Johnson & Johnson vaccine

World Health Organization grants emergency use authorization to Johnson & Johnson vaccine

The World Health Organization on Friday granted emergency use authorization to the COVID-19 vaccine developed by Johnson & Johnson
JNJ,
+0.28%
and added it to its Covax program, which aims to ensure vaccine equity for lower income countries. “Every new, safe and effective tool against COVID-19 is another step closer to controlling the pandemic,” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. “But the hope offered by these tools will not materialize unless they are made available to all people in all countries.” The J&J vaccine has the advantage over others that it requires just one dose and does not have the same refrigeration requirements as the vaccines developed by Pfizer Inc.
PFE,
+0.45%
and German partner BioNTech SE
BNTX,
-2.01%,
or the one developed by Moderna Inc.
MRNA,
-3.51%.
Those two shots require two doses weeks apart. Johnson & Johnson shares rose 0.3% Friday and are up 27% in the last 12 months.

Read More from www.marketwatch.com

The best source of news - newszf.com
Logo
Compare items
  • Total (0)
Compare
0